The use of pentoxifylline in the treatment of type 2 reactional episodes in leprosy

Indian Journal of Leprosy

Volumn 72, Issue 4, 2000, Pages 457-467

  Nery, J A C ^a   Perisse A R S ^a   Sales, A M ^a   Vieira, L M M ^a   Souza, R V ^a   Sampaio, E P ^a   Sarno, E N ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PENTOXIFYLLINE; STEROID; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; DRUG TOLERABILITY; ERYTHEMA NODOSUM LEPROSUM; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INVOLUTION; LEPROSY; MALE; NEUROPATHY; PROTEIN SECRETION; REMISSION; RETROSPECTIVE STUDY; SKIN INFLAMMATION; TREATMENT OUTCOME;

ADULT; AGED; ERYTHEMA NODOSUM; FEMALE; HUMANS; LEPROSY; MALE; MIDDLE AGED; PENTOXIFYLLINE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0034495050     PISSN: 02549395     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy: Experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia
2. Erythema nodosum leprosum in subgroups of lepromatous leprosy
3. Erythema nodosum leprosum in leprosy
4. Joint chemotherapy trials in lepromatous leprosy conducted in Thailand, the Philippines and Korea
5. Reactions in leprosy: A study of 250 patients in a multidrug therapy project, Baroda district, Gujarat, India
6. Teratogenic activity of thalidomide and related compounds
7. Observations on erythema nodosum leprosum: Clinical evaluation studies in lepromatous leprosy
8. Comparison of colchicine and aspirin in the treatment of type 2 lepra reaction
9. Indomethacin in the management of erythema nodosum leprosum - A double-blind controlled trial
10. The management of erythema nodosum leprosum: Current and future options
11. Erythema nodosum leprosum
12. Hypothesis: Erythema nodosum leprosum is precipitated by an imblance of T-lymphocytes
13. Cytokine gene expression in leprosy: A possible role for IFNγ and IL-12 in reactions (RR and ENL)
14. Thalidomide exerts its inhibitory action on TNFα by enhancing mRNA degradation
15. Erythema nodosum leprosum
16. Treatment of reactions and nerve damage
17. IgG antibody subclasses, tumor necrosis factor and IFNγ levels in patients with type 2 lepra reaction on thalidomide treatment
18. Clinical leprosy
19. A report on the use of chloroquine sulphate in lepra reaction
20. Classification of leprosy according to immunity: A five group system
21. Significance of variations within the lepromatous group
22. Serum levels of tumour necrosis factor-α and interleukin-1β during leprosy reactional states
23. Is pentoxifylline a viable alternative in the treatment of ENL?
24. Use of colchicine in the management of ENL
25. Filterability of subpopulations of leukocytes: Effects of pentoxifylline
26. The haemorheological and antithrombotic potential of pentoxifylline (Trental): A review
27. Epidemiologic characteristics of leprosy reactions
28. Reactions in leprosy: Clinical aspects
29. Reactions in leprosy - A prospective study of clinical, bacteriological, immunological, and histopathological parameters in thirty-five Indians
30. The treatment of lepra reaction in lepromatous leprosy: Fifteen years experience with thalidomide
31. Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential uses
32. Effect of cyclosporine A in erythema nodosum leprosum
33. Erythema nodosum leprosum
34. Alguns aspectos clinicos da reação tipo II em pacientes hansenianos submetidos à poliquimioterapia
35. Pentoxifylline: A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy
36. Chemotherapeutic trials in leprosy: V. Study of methods used in clinical trials in lepromatous leprosy
37. An internally-controlled double blind trial of thalidomide in severe erythema nodosum leprosum